Nebenwirkungen · Keppra
Keppra 1000 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 60–61
HOS-090836 · Präparat HOS-084117
60 Frequency category MedDRA SOC Very common Common Uncommon Rare Very rare Respiratory, Cough thoracic and mediastinal disorders Gastrointestinal Abdominal Pancreatitis disorders pain, diarrhoea, dyspepsia, vomiting, nausea Hepatobiliary Liver function Hepatic failure, disorders test abnormal hepatitis Skin and Rash Alopecia, Toxic epidermal subcutaneous eczema, necrolysis, tissue disorders pruritus, Stevens-Johnson syndrome, erythema multiforme Musculoskeletal Muscular Rhabdomyolysis and connective weakness, and blood tissue disorders myalgia creatine phosphokinase increased(3) Renal and Acute kidney urinary injury disorders General Asthenia/ disorders and fatigue administration site conditions Injury, Injury poisoning and procedural complications (1) See Description of selected adverse reactions. (2) Very rare cases of development of obsessive-compulsive disorders (OCD) in patients with underlying history of OCD or psychiatric disorders have been observed in post-marketing surveillance. (3) Prevalence is significantly higher in Japanese patients when compared to non-Japanese patients.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-01T12:51:00Z · SHA-256 0c9c2dbe2cf9e6cd5c8f5c1f489027f4a1e9204a5531ad8b866e3bc0e64b2e72 · Passage d9789754fb84e3bacdac0e802756f3d1b3f69446c501c74130b178fe1d7088fa · Zeichen 4958–7360 im Abschnitt